Literature DB >> 22444075

New adoptive immunotherapy strategies for solid tumours with CIK cells.

Sharmilan Thanendrarajan1, Young Kim, Ingo Schmidt-Wolf.   

Abstract

INTRODUCTION: Despite development and introduction of new and innovative drugs, a large number of malignant diseases are associated with unfavourable prognosis. In recent years, considerable progress in cancer treatment has been obtained by the application of cytokine-induced killer (CIK) cells. AREAS COVERED: This review provides an overview and summary of recent advances in adoptive immunotherapy strategies in cancer treatment using CIK cells. A selective literature search has been performed. EXPERT OPINION: The application of CIK cells as adoptive immunotherapy plays an important role in cancer treatment. Combining CIK cells with other conventional and established therapy options represents an innovative approach and will hopefully provide new insight for the future.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22444075     DOI： 10.1517/14712598.2012.668879

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN： 1471-2598            Impact factor:   4.388


  17 in total

1.  Meta-analysis of chemotherapy and dendritic cells with cytokine-induced killer cells in the treatment of non-small-cell lung cancer.

Authors:  Chenhong Zheng; Ganjun Yu; Hui Wang; Airong Tang; Peiliang Geng; Huiming Zhang; Zhiquan Zhu; Fang Li; Xiaohua Xie
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  The phenotype of ex vivo generated cytokine-induced killer cells is associated with overall survival in patients with cancer.

Authors:  Ke Pan; Qi-Jing Wang; Qing Liu; Hai-Xia Zheng; Yong-Qiang Li; De-Sheng Weng; Jian-Jun Li; Li-Xi Huang; Jia He; Shi-Ping Chen; Miao-La Ke; Yi-Xin Zeng; Jian-Chuan Xia
Journal:  Tumour Biol       Date:  2013-08-17

3.  Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).

Authors:  Leonard Christopher Schmeel; Frederic Carsten Schmeel; Christoph Coch; Ingo G H Schmidt-Wolf
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-08       Impact factor: 4.553

Review 4.  Cell-based immunotherapy with cytokine-induced killer (CIK) cells: From preparation and testing to clinical application.

Authors:  Yiming Meng; Zhifu Yu; Yefeng Wu; Tianzhao Du; Shi Chen; Fanjuan Meng; Nan Su; Yushu Ma; Xiaoxi Li; Sulan Sun; Guirong Zhang
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

5.  A comparison between cytokine- and bead-stimulated polyclonal T cells: the superiority of each and their possible complementary role.

Authors:  Weng-Chee Chan; Yeh-Ching Linn
Journal:  Cytotechnology       Date:  2014-12-07       Impact factor: 2.058

6.  Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer.

Authors:  Qiu-Zhong Pan; Yan Tang; Qi-Jing Wang; Yong-Qiang Li; Li Zhang; Xiao-Dong Li; Jing-Jing Zhao; De-Sheng Weng; Qing Liu; Li-Xi Huang; Jia He; Shi-Ping Chen; Miao-La Ke; Yi-Xin Zeng; Jian-Chuan Xia
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

7.  A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma.

Authors:  Li Xu; Jun Wang; Yuhree Kim; Ze-Yu Shuang; Yao-Jun Zhang; Xiang-Ming Lao; Yong-Qiang Li; Min-Shan Chen; Timothy M Pawlik; Jian-Chuan Xia; Sheng-Ping Li; Wan-Yee Lau
Journal:  Oncoimmunology       Date:  2015-10-12       Impact factor: 8.110

8.  A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma.

Authors:  Qiu-Zhong Pan; Qi-Jing Wang; Jia-Qiang Dan; Ke Pan; Yong-Qiang Li; Yao-Jun Zhang; Jing-Jing Zhao; De-Sheng Weng; Yan Tang; Li-Xi Huang; Jia He; Shi-Ping Chen; Miao-La Ke; Min-Shan Chen; Max S Wicha; Alfred E Chang; Yi-Xin Zeng; Qiao Li; Jian-Chuan Xia
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

9.  Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine-induced killer cells.

Authors:  Dengrui Li; Sumin Guo; Hui Li; Guiyun Zhu; Li Gao; Xin Xin; Dandan Yan; Xiuwu Li; Shujun Geng; Hongwei Hou; Yonghui Yang
Journal:  Thorac Cancer       Date:  2014-12-29       Impact factor: 3.500

10.  Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.

Authors:  Ying Pan; Qianshan Tao; Huiping Wang; Shudao Xiong; Rui Zhang; Tianping Chen; Lili Tao; Zhimin Zhai
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.